ARCHIVES

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

This article is from The Cancer Letter archive.

Vol. 05 No. 40 | October 5, 1979

Download PDF Visit The Full Archive

Related Articles

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

Clinical Trials Approved By NCI

November 28, 2003

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013